[{"Assets_0_Q3_USD":299751000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":94146000.0,"NetIncomeLoss_1_Q3_USD":17747000.0,"NetIncomeLoss_3_Q3_USD":53402000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":126159000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":127167000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":115798000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":115394000.0,"StockholdersEquity_0_Q3_USD":259545000.0,"EarningsPerShareBasic_1_Q3_USD":0.15,"EarningsPerShareBasic_3_Q3_USD":0.46,"EarningsPerShareDiluted_1_Q3_USD":0.14,"EarningsPerShareDiluted_3_Q3_USD":0.42,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":64445000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":184416000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181102"}]